Company
Investment-firm
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Malin Corporation
Malin Corporation is a venture capital firm based in Dublin that invests in innovative life sciences and healthcare technologies.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
Birk Venture
Birk Venture is a Scandinavian venture capital firm that focuses on investing in early-stage companies in the life science industry.
Sector
Subsector
Location
count Of Investments
Rhapsody Venture Partners
Rhapsody Venture Partners invests in and operates industrial science start-ups.
Sector
Subsector
Location
count Of Investments
Axcend Health
Axcend Health is a global venture-building firm that invests in innovative teams and companies around cutting edge advances in life science.
Sector
Subsector
Location
Financials
Investments109
Marea Therapeutics
Marea is a biotechnology firm that uses the advancements in human genetics next-generation medications for cardiometabolic illnesses.
total rounds
total raised
Marea Therapeutics
Marea is a biotechnology firm that uses the advancements in human genetics next-generation medications for cardiometabolic illnesses.
total rounds
total raised
Syncopation Life Sciences
Syncopation Life Sciences is advancing a new generation of adoptive cell therapies for cancers.
Sector
Subsector
Keywords
Location
total rounds
total raised
Co-Investors
Exits11
Afferent Pharmaceuticals
Afferent Pharmaceuticals is developing medicines to treat chronic pain.
Sector
Subsector
Location
total rounds
total raised
Corvia Medical
Corvia Medical is revolutionizing heart failure treatment with a novel transcatheter structural heart device.
Sector
Subsector
Keywords
Location
total rounds
total raised
Foundation Medicine
Foundation Medicine creates personalized cancer therapies using genetic sequencing technology.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
People
Founders3
Robert Tepper
Bob Tepper is a co-founder of Third Rock Ventures and a distinguished scientist with more than 30 years of experience building and operating leading R&D organizations in the biotech industry. Bob focuses on the formation, development and scientific strategy of our portfolio companies, as well as actively identifying and evaluating new investments. Prior to joining Third Rock, Bob was president of R&D at Millennium Pharmaceuticals and was vital in its expansion from a drug discovery company to a fully integrated biopharmaceutical company. Earlier, Bob co-founded Cell Genesys/Abgenix. Bob holds an A.B. in biochemistry from Princeton University and received his M.D. from Harvard Medical School. Bob currently serves as an adjunct faculty member at Harvard Medical School and Massachusetts General Hospital and is an advisory board member of several leading health care institutions, including the Partners HealthCare Center for Personalized Genetic Medicine, Harvard Medical School and Tufts Medical School. Bob is on the Board of Overseers at Tufts University. He also serves on the Council of the National Center for the Advancement of Translational Sciences (NCATS) at the National Institutes of Health (NIH). Bob participated in the 1972 Olympic Games in Munich, Germany.
current job
Robert Tepper
Mark Levin
Mark Levin is the Interim CEO, a member of the Board of Directors, and a Partner at Third Rock Ventures. He is an industry visionary with 40 years of experience, including more than 30 years of launching and building leading biotech companies. Mr. Levin co-founded Third Rock Ventures in 2007 and focuses on the formation, development, and business strategy of its portfolio companies, as well as actively identifying and evaluating new investments. Before Third Rock, Mr. Levin was co-founder of Mayfield Fund's life sciences effort, where he was also the founding CEO of Tularik, Cell Genesys/Abgenix, Focal, Stem Cells, and Millennium Pharmaceuticals. Mr. Levin served as CEO of Millennium Pharmaceuticals for 12 years. Earlier in his career, he was an engineer and project leader at Eli Lilly and Genentech. He is a member of the National Academy of Engineering and the Friends of Personalized Medicine, and he co-founded the Possible Project in Cambridge, Mass. Mr. Levin holds an M.S. in chemical and biochemical engineering from Washington University.
current job
Mark Levin
Kevin Starr
Kevin Starr is a proven operational leader with more than 25 years of experience building and operating leading biotech companies. Mr. Starr co-founded Third Rock Ventures in 2007 and focuses on the formation, development, and business strategy of the firm's portfolio companies as well as actively identifying and evaluating new investments. Before Third Rock Ventures, Mr. Starr was Chief Operating Officer and Chief Financial Officer at Millennium Pharmaceuticals, where he led key roles in raising billions of dollars in capital through strategic alliances and public financing and driving growth through company expansion and mergers and acquisitions. Earlier in his career, he served in various executive roles at Millennium BioTherapeutics, Biogen, and Digital Equipment Corporation. He is currently a Board Member and Start-Up CEO of Sage Therapeutics. Mr. Starr holds an M.S. in Corporate Finance from Boston College and a B.A. in Mathematics and Business from Colby College.
current job
Kevin Starr
Employee Profiles120
Activity
Recent News15
The graph reveals the ratio (%) of positive news articles in a chosen time range